Use access key #2 to skip to page content.
$4.35 -0.40 (-8.42%)
10/7/2008 3:45 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

4

Avatar cunnin7003 (95.94) Submitted: 9/29/06 5:16 PM : Outperform Start Price: $9.00 EXEL Score: -26.47

I've owned this stock for a while, haven't seen any upside yet, but it's coming... someday... Will try to add to my position over time, because in 10 years this could make us all rich.

Report this Post Replies: 0 | Reply

Featured Broker Partners